Thomas E Beck, OD | |
2402 S 1st St Ste 114, Yakima, WA 98903-1646 | |
(509) 591-9277 | |
(509) 737-8935 |
Full Name | Thomas E Beck |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 35 Years |
Location | 2402 S 1st St Ste 114, Yakima, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427108372 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 1852 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beck And Beck Inc | 2264653237 | 2 |
News Archive
Statistical models are playing an increasingly important role in risk analysis and helping the United States and other countries around the globe mitigate the effects of natural and man-made disasters, said Siddhartha (Sid) Dalal during a presentation at the 2015 Joint Statistical Meetings (JSM 2015) yesterday in Seattle.
A just-out study suggests that what keeps chronic nervous system diseases such as Alzheimer's, Huntington's and ALS going - until they overcome the internal protective mechanisms a body can throw at them - may largely come down to poor conversational skills.
Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).
New research from the University of Leicester demonstrates that psychiatrists are not offering adequate checks for metabolic complications that are common in patients with mental ill health - especially those prescribed antipsychotic medication.
Elsevier Inc., the world's leading publisher of scientific, technical and medical information, announced today that Alcohol has published a special year-end double issue on Fetal Alcohol Spectrum Disorders (FASD). It fills an urgent need to bring the widest possible readership current perspectives on using new research methods to improve identification and diagnosis of offspring at risk for FASD and its associated brain damage and behavioral dysfunction.
› Verified 3 days ago
Provider Name | Beck And Beck Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1679991889 PECOS PAC ID: 2264653237 Enrollment ID: O20141016002682 |
News Archive
Statistical models are playing an increasingly important role in risk analysis and helping the United States and other countries around the globe mitigate the effects of natural and man-made disasters, said Siddhartha (Sid) Dalal during a presentation at the 2015 Joint Statistical Meetings (JSM 2015) yesterday in Seattle.
A just-out study suggests that what keeps chronic nervous system diseases such as Alzheimer's, Huntington's and ALS going - until they overcome the internal protective mechanisms a body can throw at them - may largely come down to poor conversational skills.
Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).
New research from the University of Leicester demonstrates that psychiatrists are not offering adequate checks for metabolic complications that are common in patients with mental ill health - especially those prescribed antipsychotic medication.
Elsevier Inc., the world's leading publisher of scientific, technical and medical information, announced today that Alcohol has published a special year-end double issue on Fetal Alcohol Spectrum Disorders (FASD). It fills an urgent need to bring the widest possible readership current perspectives on using new research methods to improve identification and diagnosis of offspring at risk for FASD and its associated brain damage and behavioral dysfunction.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Thomas E Beck, OD 1360 N Louisiana St # A-744, Kennewick, WA 99336-7171 Ph: (509) 591-9277 | Thomas E Beck, OD 2402 S 1st St Ste 114, Yakima, WA 98903-1646 Ph: (509) 591-9277 |
News Archive
Statistical models are playing an increasingly important role in risk analysis and helping the United States and other countries around the globe mitigate the effects of natural and man-made disasters, said Siddhartha (Sid) Dalal during a presentation at the 2015 Joint Statistical Meetings (JSM 2015) yesterday in Seattle.
A just-out study suggests that what keeps chronic nervous system diseases such as Alzheimer's, Huntington's and ALS going - until they overcome the internal protective mechanisms a body can throw at them - may largely come down to poor conversational skills.
Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).
New research from the University of Leicester demonstrates that psychiatrists are not offering adequate checks for metabolic complications that are common in patients with mental ill health - especially those prescribed antipsychotic medication.
Elsevier Inc., the world's leading publisher of scientific, technical and medical information, announced today that Alcohol has published a special year-end double issue on Fetal Alcohol Spectrum Disorders (FASD). It fills an urgent need to bring the widest possible readership current perspectives on using new research methods to improve identification and diagnosis of offspring at risk for FASD and its associated brain damage and behavioral dysfunction.
› Verified 3 days ago
Winters Vision, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1600 E Chestnut Ave, Yakima, WA 98901 Phone: 509-576-3989 Fax: 509-834-7400 | |
Miranda Hueners, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1410 Lakeside Ct Ste 103, Yakima, WA 98902 Phone: 509-453-2010 | |
Dr. Kaleb A Dieker, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1211 S 40th Ave, Yakima, WA 98908 Phone: 509-966-2966 Fax: 509-966-3230 | |
Ronald Delano Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1600 E Chestnut Ave, Yakima, WA 98901 Phone: 509-576-3989 Fax: 509-576-4375 | |
Vic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 303 E D St Ste 4, Yakima, WA 98901 Phone: 509-452-8301 | |
Evan Beus Od Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 2410 Terrace Heights Dr Ste B, Yakima, WA 98901 Phone: 509-966-0675 Fax: 509-823-4433 | |
Eyecare Associates Yakima Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3909 Creekside Loop Ste 150, Yakima, WA 98902 Phone: 509-303-1031 |